Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study

Published:2024-09 Issue:9 Volume:22 Page:2589-2600
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Dubut Jade,Goin Valérie,Derray Cloé,Huguenin Yoann,Fiore Mathieu^ORCID

Publisher

Elsevier BV

Reference50 articles.

1. Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy;Nurden;Haematologica,2021

2. Glanzmann thrombasthenia: perspectives from clinical practice on accurate diagnosis and optimal treatment strategies;Mathews;J Blood Med,2021

3. ClinGen Platelet Disorder Variant Curation Expert Panel. Glanzmann thrombasthenia: genetic basis and clinical correlates;Botero;Haematologica,2020

4. Expanding the mutation spectrum affecting αIIbβ3 integrin in Glanzmann thrombasthenia: screening of the ITGA2B and ITGB3 genes in a large international cohort;Nurden;Hum Mutat,2015

5. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models;Nurden;Blood,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP